SETDB1 is known to contribute to the EMT process in breast cancer by interacting with the SMAD/ transforming growth factor-beta (TGF-B) regulatory pathway that influences EMT-inducing transcription factors such as zinc finger protein SNAI1 (Snail-1). Here, SETDB1 is linked to breast cancer.